Company Overview and News
Hardey Resources Ltd (ASX:HDY) has entered into a share sale agreement with Vanadium Mining Pty Ltd to acquire six highly prospective vanadium projects in Queensland and the Northern Territory.
IRC TNG HRDDF
Intermin Resources Ltd (ASX:IRC) has received results from a three hole reverse circulation (RC) program testing southern extensions at the Goongarrie Lady gold project near Kalgoorlie.
Intermin Resources Ltd (ASX:IRC) has received assays from initial resource drilling at its 100% owned Binduli gold project near Kalgoorlie in Western Australia.
Intermin Resources Limited (ASX:IRC) has revealed its feasibility study findings for the Goongarrie Lady gold project in Western Australia, indicating a technically strong and financially viable project.
Intermin Resources Limited (ASX:IRC) has completed full reconciliation of the mine physicals of its ore processing campaign at the Lakewood toll milling facility.
Intermin Resources Ltd (ASX:IRC) managing director Jon Price speaks to Proactive Investors about the Australia-focused company's progress as it works to "enter the realms of mid-tier gold production."
Intermin Resources Ltd (ASX:IRC) continues to execute its company strategy of acquiring quality assets on major geological structures contiguous with existing landholdings, while being in close proximity to supporting infrastructure.
Intermin Resources Ltd (ASX:IRC) is set to gain from any exploration discovery made by Eastern Goldfields Ltd (ASX:EGS) at its Menzies joint venture in Western Australia.
IRC EGS EGDD ESGFF
Intermin Resources Limited (ASX:IRC) has received further positive drilling results from the its Teal gold project located 11 kilometres northwest of Kalgoorlie-Boulder in Western Australia.
Intermin Resources Limited (ASX:IRC) and joint venture partner AXF have received positive initial metallurgical test work results from the Lilyvale prospect area, part of the Richmond vanadium project.
Intermin Resources Limited (ASX:IRC) has released further results from reverse circulation drilling at its new discovery targets at the Teal Gold Project.
Intermin Resources, owners of several Western Australian gold interests, has posted positive results from RC (reverse circulation) drilling of the Jacques Find and Yolande deposits at the Teal gold project, 11km northwest of Kalgoorlie.
Intermin Resources Limited (ASX:IRC) has received promising reverse circulation (RC) drilling results from the 100%-owned Teal Gold Project.
Intermin Resources Limited (ASX:IRC) has adopted a strategy of entering into joint ventures for most of its broad range of projects which predominantly span base and precious metals.
IRC EGS EGDD ESGFF
Intermin Resources Limited (ASX:IRC) has found additional gold within and below the open pit of the Teal Gold Project in Western Australia, prompting a production guidance increase.
3h - Asif
Overview Adaptimmune Therapeutics is a clinical-stage biopharmaceutical company focused on providing novel cell therapies to patients, particularly in solid tumors. The company's comprehensive and proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors (“TCRs”), and produce therapeutic candidates for administration to patients. Using its affinity engineered TCRs, the company aim to become a fully integrated cell therapy company and to be the first company to have a TCR T-cell approved for a solid tumor indication. Adaptimmune Therapeutics has four SPEAR T-cells in clinical trials, MAGE-A10, MAGE-A4, AFP and NY-ESO. Phase 1/2 clinical trials are ongoing in patients with various cancer tumor types including urothelial, melanoma, head and neck, ovarian, esophageal, gastric, multiple myeloma, hepatocellular cancers and in synovial sarcoma, myxoid round cell liposarcoma...
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
Silicon Investor Message Boards
This table lists all message boards related to ASX:IRC / INTERMIN RESOURCES LIMITED on message board site Silicon Investor.